PfizerWorks: New Outsourcing Model to Improve Employee Productivity
|
|
ICMR HOME | Case Studies Collection
Case Details:
Case Code : OPER081
Case Length : 13 Pages
Period : 2005-2009
Organization : Pfizer, Inc.
Pub Date : 2009
Teaching Note :Not Available
Countries : US
Industry : Pharmaceuticals
To download PfizerWorks: New Outsourcing Model to Improve Employee Productivity case study
(Case Code: OPER081) click on the button below, and select the case from the list of available cases:
Price:
For delivery in electronic format: Rs. 300;
For delivery through courier (within India): Rs. 300 +Shipping & Handling Charges extra
»
Operations Case Studies
» Operations Short Case Studies
» View Detailed Pricing Info
» How To Order This Case
» Business Case Studies
» Case Studies by Area
» Case Studies by Industry
» Case Studies by Company
Please note:
This case study was compiled from published sources, and is intended to be used as a basis for class discussion. It is not intended to illustrate either effective or ineffective handling of a management situation. Nor is it a primary information source.
Chat with us
Please leave your feedback
|
|
<< Previous
Excerpts Contd...
Results
In early 2009, Cohen said that the PfizerWorks program was estimated to have freed up over 60,500 hours for employees since it was introduced in early 2008. In addition to achieving its primary objective of freeing up executives' time so that they could focus on higher-level tasks, it had also led to a reduction in project-related costs...
What People Say
Most industry observers appreciated the fact that the PfizerWorks program resulted in cost reduction and improvement in efficiency without eliminating jobs in the US.
|
|
They felt that, in addition to being time consuming, support work of a menial nature was also a source of frustration for employees...
Outlook
As of 2009, the PfizerWorks initiative was open to around 4,000 employees and the employees were more than impressed with the initiative. Industry observers felt that more companies would be trying out similar initiatives in the future, particularly with the economic situation continuing to be grim...
Exhibits
Exhibit I: Pfizer's Five Year Financial Summary: 2004-2008
Exhibit II: Pfizer's Revenue Break-up by Region: 2008
Exhibit III: Pfizer's Problems in 2005
Exhibit VI: A Brief Note on Job Analysis
Exhibit V: A Brief Note on the World is Flat: A Brief History of the
Twenty-First Century
|
|
